Actgen Pharma plans expansion of its bulk drug unit at Panoli

Details

Category: Bulk Drug Manufacturing

Actgen Pharma plans expansion of its bulk drug unit at Panoli in Bharuch district in Gujarat with an investment of Rs. 78.5 million. The project involves expanding bulk drugs manufacturing capacity from 2.0 MTPM to 8.12 MTPM to manufacture Ciprofloxacin HCl, Ofloxacin Base, Enrofloxacin Base, Levofloxacin Hemihydrate, Difloxacin HCl, Sarafloxacin HCl, Norfloxacin Base among other chemicals.

• < Prev
• Next >